Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study

Key Points After consolidation rdWBRT in a subset of patients, most of the patients exhibited sustained or improved cognitive function. rdWBRT should be considered a strong consolidation treatment for PCNSL in patients aged <60 years showing CR after induction chemotherapy.

[1]  T. Kim,et al.  Reduced-dose whole-brain radiotherapy with tumor bed boost after upfront high-dose methotrexate for primary central nervous system lymphoma , 2020, Radiation oncology journal.

[2]  G. Winocur,et al.  Cancer-Related Cognitive Impairment: An update on state of the art, detection, and management strategies in cancer survivors. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  D. Correa,et al.  Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation , 2019, Journal of Neuro-Oncology.

[4]  K. Hoang-Xuan,et al.  Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  V. Sreenivas,et al.  A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome , 2018, Journal of Neuro-Oncology.

[6]  Y. Hasegawa,et al.  A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine. , 2017, Journal of clinical and experimental hematopathology : JCEH.

[7]  K. Hoang-Xuan,et al.  Whole Brain Radiotherapy (WBRT) Versus Intensive Chemotherapy with Haematopoietic Stem Cell Rescue (IC + HCR) for Primary Central Nervous System Lymphoma (PCNSL) in Young Patients: An Intergroup Anocef-Goelams Randomized Phase II Trial (PRECIS) , 2016 .

[8]  R. Pfeiffer,et al.  Trends in primary central nervous system lymphoma incidence and survival in the U.S. , 2016, British journal of haematology.

[9]  J. Baars,et al.  Neurocognitive function of lymphoma patients after treatment with chemotherapy , 2016, Acta oncologica.

[10]  B. O'neill,et al.  Stereotactic Radiosurgery in the Treatment of Recurrent CNS Lymphoma. , 2015, World neurosurgery.

[11]  S. Belleville,et al.  Normative data for the Rey-Osterrieth and the Taylor complex figure tests in Quebec-French people. , 2015, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[12]  Wolfgang A Tome,et al.  Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  P. Schatz,et al.  Comparing post-concussive neurocognitive test data to normative data presents risks for under-classifying "above average" athletes. , 2014, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[14]  D. Correa,et al.  Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. Reynolds,et al.  Improving Test Interpretation for Detecting Executive Dysfunction in Adults and Older Adults: Prevalence of Low Scores on the Test of Verbal Conceptualization and Fluency , 2012, Applied neuropsychology. Adult.

[16]  K. Hoang-Xuan,et al.  Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred? , 2011, Journal of Neuro-Oncology.

[17]  J. Fike,et al.  CNS complications of radiotherapy and chemotherapy , 2009, The Lancet.

[18]  D. Hartman,et al.  Wechsler Adult Intelligence Scale IV (WAIS IV): Return of the Gold Standard , 2009, Applied neuropsychology.

[19]  M. Taniwaki,et al.  Effectiveness and Limitation of Gamma Knife Radiosurgery for Relapsed Central Nervous System Lymphoma: A Retrospective Analysis in One Institution , 2007, International journal of hematology.

[20]  H. Amièva,et al.  [Cued and uncued memory tests: norms in elderly adults from the 3 Cities epidemiological study]. , 2007, Revue neurologique.

[21]  J. Dartigues,et al.  Test de rappel libre/rappel indicé à 16 items : normes en population générale chez des sujets âgés issues de l’étude des 3 Cités , 2007 .

[22]  L. Deangelis,et al.  Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  D. Correa,et al.  Delayed neurotoxicity in primary central nervous system lymphoma. , 2005, Archives of neurology.

[24]  J. Armitage,et al.  Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  L. Deangelis,et al.  Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Michael J. Taylor,et al.  Sensitivity and specificity of WAIS–III/WMS–III demographically corrected factor scores in neuropsychological assessment , 2001, Journal of the International Neuropsychological Society.

[27]  A. López-Guillermo,et al.  CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma. , 2001, International journal of radiation oncology, biology, physics.

[28]  L. Deangelis,et al.  Treatment for primary CNS lymphoma: the next step. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  F. Hochberg,et al.  Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. , 1994, Journal of neurosurgery.

[30]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[31]  D. Reardon,et al.  Low-dose whole brain radiotherapy combined with radiosurgery for primary CNS lymphoma achieving partial response to induction methotrexate-based chemotherapy. , 2014, Journal of radiosurgery and SBRT.

[32]  G Deloche,et al.  Diversity of patterns of improvement in confrontation naming rehabilitation: some tentative hypotheses. , 1997, Journal of communication disorders.

[33]  P. Biron,et al.  The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression. , 1995, Blood.

[34]  Y. Joanette,et al.  [Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level]. , 1990, Acta neurologica Belgica.

[35]  Christie Golden,et al.  Stroop Color and Word Test: Manual for Clinical and Experimental Uses. , 1978 .